About Helsingin yliopistollinen keskussairaala, Meilahden sairaala
Meilahden tornisairaala on HYKS-sairaanhoitoalueeseen kuuluva sairaala. Sairaalan nimi vaihdettiin vuonna 2010 jotta sairaala erottuisi alueen monista muista HUS-sairaaloista. Sairaala sijaitsee Helsingissä Meilahden kaupunginosassa, ja sen katuosoite on Haartmaninkatu 4.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Helsingin yliopistollinen keskussairaala, Meilahden sairaala
During the past decade, Helsingin yliopistollinen keskussairaala, Meilahden sairaala conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs)
2008-12-12
2017-07-27
Completed
2,825
A Study to Assess Hemoglobin Level Depending on the Comorbidity Index in Chronic Kidney Disease (CKD) Participants Not in Dialysis Treated With Methoxy Polyethylene Glycol-Epoetin Beta (COMETE)
2012-11-21
2015-03-25
Completed
551
GENetic & Immunologic Abnomalies in Systemic Lupus Erythematosus
2013-10-01
2016-10-01
Completed
271
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Helsingin yliopistollinen keskussairaala, Meilahden sairaala"
#1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Helsingin yliopistollinen keskussairaala, Meilahden sairaala
According to Clinical.Site data, the most researched conditions in "Helsingin yliopistollinen keskussairaala, Meilahden sairaala" are
"Prostate Cancer" (2 trials), "Cancer of the Prostate" (1 trials), "Hemophilia A" (1 trials) and "Nonmetastatic Castration-Resistant Prostate Cancer" (1 trials). Many other conditions were trialed in "Helsingin yliopistollinen keskussairaala, Meilahden sairaala" in a lesser frequency.
Clinical Trials Intervention Types at Helsingin yliopistollinen keskussairaala, Meilahden sairaala
Most popular intervention types in "Helsingin yliopistollinen keskussairaala, Meilahden sairaala" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Enzalutamide" (2 trials), "Abiraterone" (1 trials), "Emicizumab" (1 trials), "Placebo" (1 trials) and "Placebo for Enzalutamide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Helsingin yliopistollinen keskussairaala, Meilahden sairaala
The vast majority of trials in "Helsingin yliopistollinen keskussairaala, Meilahden sairaala" are
2 trials for "Male" genders and 1 trials for "All" genders.
Clinical Trials Status at Helsingin yliopistollinen keskussairaala, Meilahden sairaala
Currently, there are NaN active trials in "Helsingin yliopistollinen keskussairaala, Meilahden sairaala".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Helsingin yliopistollinen keskussairaala, Meilahden sairaala,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Helsingin yliopistollinen keskussairaala, Meilahden sairaala, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".